Postmarketing studies of drug safety

被引：8

作者：

Schneeweiss, Sebastian

Avorn, Jerry

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷

关键词：

CLINICAL-TRIALS;

D O I：

10.1136/bmj.d342

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 12 条

[1]

AGABITI N, 2010, LONG TERM OUTCOMES A

[2]

Andrews Elizabeth B., 1996, Pharmacoepidemiology and Drug Safety, V5, P333

[3]

*EUR NETW CTR PHAR, 2010, ENCEPP STUD

[4] Selective prescribing led to overestimation of the benefits of lipid-lowering drugs [J].

Glynn, Robert J. ;

Schneeweiss, Sebastian ;

Wang, Philip S. ;

Levin, Raia ;

Avorn, Jerry .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (08) :819-828

[5] Evaluating medication effects outside of clinical trials: New-user designs [J].

Ray, WA .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (09) :915-920

[6]

SCHNEEWEISS S, 2008, NEW ENGL J MED, V358, P840

[7] A basic study design for expedited safety signal evaluation based on electronic healthcare data [J].

Schneeweiss, Sebastian .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (08) :858-868

[8] Observational research, randomised trials, and two views of medical science [J].

Vandenbroucke, Jan P. .

PLOS MEDICINE, 2008, 5 (03) :339-343

[9] Preregistration of Epidemiologic Studies An Ill-founded Mix of Ideas [J].

Vandenbroucke, Jan P. .

EPIDEMIOLOGY, 2010, 21 (05) :619-620

[10] Risk of death in elderly users of conventional vs. atypical antipsychotic medications [J].

Wang, PS ;

Schneeweiss, S ;

Avorn, J ;

Fischer, MA ;

Mogun, H ;

Solomon, DH ;

Brookhart, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (22) :2335-2341

← 1 2 →